Biggest News Aggregation in the World
๐Ÿ“ฐ Allo News

Page 6 - Allo News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Allo. Real-time updates on events, politics, business and more.

Allogene Therapeutics (NASDAQ:ALLO) Coverage Initiated by Analysts at Citigroup

Citigroup started coverage on shares of Allogene Therapeutics (NASDAQ:ALLO – Free Report) in a research note released on Friday morning, MarketBeat Ratings reports. The firm issued a buy rating and a $7.00 target price on the stock. ALLO has been the topic of a number of other research reports. JPMorgan Chase & Co. cut their […]
Blackrock Inc Pricet Rowe Associates Inc Jpmorgan Chase Co Allogene Therapeutics Inc Allogene Therapeutics Free Report

Allogene Therapeutics (ALLO) Scheduled to Post Quarterly Earnings on Thursday

Allogene Therapeutics (NASDAQ:ALLO – Get Free Report) will be announcing its earnings results after the market closes on Thursday, November 2nd. Analysts expect the company to announce earnings of ($0.53) per share for the quarter. Allogene Therapeutics (NASDAQ:ALLO – Get Free Report) last posted its earnings results on Wednesday, August 2nd. The company reported ($0.53) […]
United States Stephen Mayo Jpmorgan Chase Co Allogene Therapeutics Inc Wells Fargo Company Nuveen Asset Management
Source: wkrb13.com

Allogene Therapeutics (NASDAQ:ALLO) Reaches New 12-Month Low at $2.88

Allogene Therapeutics, Inc. (NASDAQ:ALLO – Get Free Report) reached a new 52-week low during mid-day trading on Thursday . The company traded as low as $2.88 and last traded at $3.03, with a volume of 486164 shares changing hands. The stock had previously closed at $3.08. Analysts Set New Price Targets A number of brokerages […]
Stephen Mayo Capital Management Shikiar Asset Management Inc Harbor Capital Advisors Inc Allogene Therapeutics Inc Ieq Capital

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News โ†’

Allogene Therapeutics (NASDAQ:ALLO) Reaches New 52-Week Low at $2.88

Allogene Therapeutics, Inc. (NASDAQ:ALLO – Get Free Report)’s stock price reached a new 52-week low during mid-day trading on Wednesday . The company traded as low as $2.88 and last traded at $3.00, with a volume of 1531650 shares traded. The stock had previously closed at $3.16. Analyst Ratings Changes ALLO has been the topic […]
Stephen Mayo Millennium Management Pricet Rowe Associates Inc Jpmorgan Chase Co Allogene Therapeutics Inc Allogene Therapeutics

Allogene Therapeutics, Inc. (NASDAQ:ALLO) Given Average Rating of "Moderate Buy" by Analysts

Shares of Allogene Therapeutics, Inc. (NASDAQ:ALLO – Get Free Report) have earned an average recommendation of “Moderate Buy” from the eleven analysts that are covering the stock, Marketbeat.com reports. One analyst has rated the stock with a sell recommendation, two have given a hold recommendation and eight have assigned a buy recommendation to the company. […]
Stephen Mayo Asset Management Inc Jpmorgan Chase Co Allogene Therapeutics Inc Ieq Capital Ci Investments Inc

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science